These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6242233)

  • 21. Serological survey of hepatitis B in northern Rwanda.
    Gascon J; Bruguera M; Corachan M; Mayor A; Sanchez Tapias JM; Rodes J
    Trop Geogr Med; 1988 Oct; 40(4):293-7. PubMed ID: 3265811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk for HBV infection and vaccination indications for health personnel and other groups at risk].
    Bigl S; Mann G; Mann W; Kempe M
    Z Arztl Fortbild (Jena); 1991 Apr; 85(7):323-6. PubMed ID: 1829564
    [No Abstract]   [Full Text] [Related]  

  • 23. [A survey of the immune effects and persistence of Chinese produced HB blood-origin vaccines].
    Liu ZQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):203-5. PubMed ID: 2805045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of hepatitis B by vaccination in 53 children at risk. Transmission of hepatitis B virus infection and its prevention].
    Zecca G; Motti G; Manzoni C; Del Curto E
    Minerva Pediatr; 1985 Sep; 37(17):593-6. PubMed ID: 2934613
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatitis B infection of the newborn by its symptom-free mother].
    Joosten R; Stürner KH
    Med Klin; 1980 Mar; 75(6):223-4. PubMed ID: 7393117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination campaign against hepatitis B in Italy.
    Stroffolini T
    Chemioterapia; 1987 Jun; 6(2 Suppl):649-50. PubMed ID: 2978390
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the immunizing potency of hematogenic hepatitis B vaccine].
    Kang P
    Zhonghua Hu Li Za Zhi; 1993 Nov; 28(11):643-5. PubMed ID: 8124773
    [No Abstract]   [Full Text] [Related]  

  • 28. [Follow-up on hepatitis B immunized neonates born to HBsAg positive mothers].
    Zhang X; Xing Y; Shen L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Mar; 32(2):97-9. PubMed ID: 10322808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vertical transmission of hepatitis B virus. 2: hepatitis B preventive vaccination of newborn infants in Mecklenburg-Vorpommern].
    Rohde S; Hülsse C; Jülich WD; Jährig D
    Z Arztl Fortbild (Jena); 1991 Aug; 85(16):755-9. PubMed ID: 1835225
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis B screening in late pregnancy and results of immunization in newborn infants].
    Sidiropoulos D; Wegmann G; Bütler R; von Muralt G
    Schweiz Med Wochenschr; 1988 Mar; 118(9):309-12. PubMed ID: 2965828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus.
    Nair PV; Weissman JY; Tong MJ; Thursby MW; Paul RH; Henneman CE
    Gastroenterology; 1984 Aug; 87(2):293-8. PubMed ID: 6376265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interruption of perinatal transmission of HBV by Chinese recombinant hepatitis B vaccine].
    Yang C; Chen D; Li S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):343-5. PubMed ID: 7874702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization.
    Coursaget P; Adamowicz P; Bourdil C; Yvonnet B; Buisson Y; Barrès JL; Saliou P; Chiron JP; Mar ID
    Vaccine; 1988 Aug; 6(4):357-61. PubMed ID: 2973189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on hepatitis B viral disease.
    Shedlofsky SI
    J Ky Med Assoc; 1988 Apr; 86(4):181-6. PubMed ID: 2966844
    [No Abstract]   [Full Text] [Related]  

  • 35. [Incidence of the HBsAg carrier state among pregnant women and its effect on newborn infants. I. The incidence of the HBsAg carrier state among pregnant women in different provinces of Bulgaria].
    Iliev B; Stambolov B; Khristov M
    Akush Ginekol (Sofiia); 1987; 26(4):43-7. PubMed ID: 3674323
    [No Abstract]   [Full Text] [Related]  

  • 36. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination].
    Lohouès-Kouacou MJ; Touré M; Hillah J; Camara BM; N'Dri N; Kouamé KJ; Attia Y
    Sante; 1998; 8(6):401-4. PubMed ID: 10064911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the efficacy of genetically engineered vaccines against hepatitis B for interruption of perinatal transmission].
    Kang P; Shen XM; Yu HM
    Zhonghua Hu Li Za Zhi; 1995 Jul; 30(7):390-2. PubMed ID: 8631089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Limited value of anti-HBs determination following vaccination against hepatitis B].
    Heijtink RA
    Ned Tijdschr Geneeskd; 1987 Aug; 131(33):1443-4. PubMed ID: 2959868
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of neonatal hepatitis B infection by high-dose hepatitis B immune globulin.
    Dosik H; Jhaveri R
    N Engl J Med; 1978 Mar; 298(11):602-3. PubMed ID: 628377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.